Amplifying the Patient Voice: Reflections from MAPS EMEA 2025
At this year’s MAPS EMEA 2025 Annual Meeting in London, the message was clear: the patient voice is central to every stage of the drug development journey, a theme eloquently showcased in the Opening General Assembly: Patient Impact on Medical Affairs. Global leaders in Medical Affairs gathered to explore how the industry can evolve from…...
Read MoreTop Stories
What’s Next for Global Capability Centers )?
The theme for this year’s NASSCOM GCC Summit, “The Next GCC...
MAPS 2025 Decoded: The Medical Affairs Playbook
At the MAPS Americas 2025 conference in New Orleans, one of...
Medical Affairs 2.0: GenAI as the Catalyst for
Digital and AI were hot topics underpinning many of the...
Filter
Maximizing Efficiency and Compliance with Expert Compendia and Monograph Review Services
Cactus Life Sciences specializes in compendia reviews, providing invaluable assistance to pharmaceutical companies. Our expert...
The Quest for Omnichannel: Is Medical Affairs Ready?
Commercial and Medical Affairs must partner with each other to achieve the real benefits of...
Breaking Barriers: Exploring the Power of AI and NLP in Scientific Communication
Learn how medical publication professionals and medical affairs teams can embrace AI and NLP tools...
Periodic Safety Update Report (PSUR): A Breakdown of MDCG 2022-21
A well-structured, clear, and concise PSUR enables a seamless notified body review. Read our key...
New Open Data Sharing Policies: WHO and NIH Take Big Steps to Improve Public Health
Making research and data reproducible is vital to improving public health and reinstating trust in...
Didactic to Dynamic: Innovative Approaches to Deeper Payer Engagements
HEOR is a fast-evolving field. Feedback from payers can influence research plans and help create...